Since FDG PET-CT is not a routine or standard imaging modality in prostate cancer, only patients with a high pretest possibility of metastasis were referred for FDG PET-CT by the urologist or oncologist, which may account for the high PSA levels and high positive rate of metastatic disease in the patients of the present study. The gene discussed is KLK3; the disease is Familial prostate cancer.